Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01004601
What this trial is testing

Low Dose Weekly Docetaxel Versus Pemetrexed in Previously Treated Advanced Non-Small-Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Chang Gung Memorial Hospital 179
Not applicableStudy completedNCT07682012
What this trial is testing

LungVision AI-Augmented Fluoroscopic Navigation for Intraoperative Pulmonary Nodule Localization

Who this might be right for
Lung NeoplasmsPulmonary Nodule, SolitaryCarcinoma, Non-Small-Cell Lung
Tri-Service General Hospital (TSGH) 14
Not applicableNot Yet RecruitingNCT07689812
What this trial is testing

Randomized Open-Label Trial Evaluating ctDNA-Guided Interruption Versus Standard of Care Immune-Checkpoint Inhibitor (ICI) Therapy In Patients With Advanced / Metastatic Solid Tumors.

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Cancer)NSCLC (Non-small Cell Lung Carcinoma)+12 more
Natera, Inc. 920
Testing effectiveness (Phase 2)Ended earlyNCT00592007
What this trial is testing

Study Evaluating the Addition of Fulvestrant to Erlotinib in Stage IIIB/IV Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Carcinoma
Lyudmila Bazhenova, M.D. 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT05500092
What this trial is testing

An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer

Who this might be right for
Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
Montefiore Medical Center 17
Testing effectiveness (Phase 2)Study completedNCT01107444
What this trial is testing

Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 180
Large-scale testing (Phase 3)Study completedNCT03689634
What this trial is testing

Move For Surgery - A Novel Preconditioning Program

Who this might be right for
Lung Cancer, Nonsmall Cell
St. Joseph's Healthcare Hamilton 102
Testing effectiveness (Phase 2)Ended earlyNCT00283634
What this trial is testing

Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Millennium Pharmaceuticals, Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT03647163
What this trial is testing

Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerNeuroendocrine Carcinoma+1 more
Vyriad, Inc. 33
Large-scale testing (Phase 3)Study completedNCT01523587
What this trial is testing

LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Boehringer Ingelheim 795
Testing effectiveness (Phase 2)Looking for participantsNCT06492421
What this trial is testing

Neoadjuvant Intra-tumor Double Immunotherapy for Lung Cancer.

Who this might be right for
Lung CancerSurgeryNon-small Cell Lung Cancer
Second Affiliated Hospital of Guangzhou Medical University 90
Not applicableStudy completedNCT00900302
What this trial is testing

OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer

Who this might be right for
Cancer
OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Active Not RecruitingNCT04143607
What this trial is testing

ASK120067 Versus Gefitinib as First-line Treatment for EGFRm Locally Advanced or Metastatic NSCLC

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 337
Early research (Phase 1)Study completedNCT02728492
What this trial is testing

Safety, Tolerability and Pharmacokinetics of Quisinostat, a Histone Deacetylase Inhibitor, in Combination With Chemotherapy

Who this might be right for
Non-small Cell Lung CancerEpithelial Ovarian Cancer
NewVac LLC 51
Testing effectiveness (Phase 2)Study completedNCT00139711
What this trial is testing

Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 138
Not applicableWithdrawnNCT05287971
What this trial is testing

Standard of Care Lifestyle Support for Stage III NSCLC Patients

Who this might be right for
Non Small Cell Lung Cancer
Maastricht Radiation Oncology
Testing effectiveness (Phase 2)UnknownNCT05016544
What this trial is testing

Inetetamab in Combination With Pyrotinib in HER2 Mutant or Amplified Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)Study completedNCT01243775
What this trial is testing

BELotaxel(Docetaxel) and bellOXa(Oxaliplatin) in Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Chonnam National University Hospital 33
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Testing effectiveness (Phase 2)Active Not RecruitingNCT06055465
What this trial is testing

Neoadjuvant Sacituzumab Govitecan Plus Pembrolizumab in Resectable Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Chinese University of Hong Kong 37
Next Page